- Omnibus Grant Solicitations for investigator-initiated applications
- Targeted Funding Opportunity Announcements (FOAs)
- Annual NIH & CDC SBIR Contract Solicitation
- Search the NIH Guide for other funding opportunities
Highlighted Funding Opportunities
- NHLBI Phase IIB Bridge Award
Up to $3 million for three years to support the next stage of development for previously funded SBIR Phase II projects. Learn more.
- NHLBI Phase IIB Small Market Award
Up to $1 million per year for three years to support the next stage of development for technologies addressing rare diseases or pediatric populations. Learn more.
- Phase II Awardees – Apply for the Commercialization Readiness Pilot (CRP) Program
The CRP program aims to facilitate the transition of previously funded SBIR/STTR Phase II projects to the commercialization stage by providing support for technical assistance not typically supported through Phase II grants or contracts. NHLBI participates in PAR-16-026 SBIR/STTR Commercialization Readiness Pilot (CRP) Program: Technical Assistance (SB1) for awards up to $50,000 based on NHLBI Phase II awards. Read NOT-HL-15-283 about NHLBI participation. Learn more about the Commercialization Readiness Pilot (CRP) funding opportunity.
General SBIR/STTR Funding Information
The NHLBI provides numerous funding opportunities for small business concerns (SBCs), using grant and contract mechanisms, and supporting targeted research areas and investigator-initiated applications.
The SBIR/STTR program is structured in three phases. The main objective in Phase I is for SBCs to establish the technical merit and feasibility of the proposed research and development (R&D) efforts, while in Phase II it is to continue the R&D efforts initiated in Phase I. The objective of Phase III is for the SBC to pursue with non-SBIR funds the commercialization of the product or service developed during its Phase II activities.
The STTR program requires a partnership between the small business and a non-profit US research institution. The small business must perform at least 40% of the work, and the research institution must perform at least 30%.
Basic information on each of the phases is described below. For more information, see About the Programs:
- Phase I: Funding for proof-of-concept or feasibility studies. Generally, up to $225,000 for six months (SBIR) to one year (STTR).
- Phase II: Funding for continued R&D effort: Generally, up to $1,500,000 for two years.
- SBIR Phase IIB: The NHLBI does not participate in the Phase IIB program through the NIH Omnibus Grant Solicitation. The NHLBI offers Phase IIB funding through two targeted funding opportunities: The Bridge Awards and the Small Market Awards.
How to Apply
To learn more about applying for funding from the National Institutes of Health (NIH), necessary forms, important deadlines, a general timeline, and guidelines for tracking your application through the process, click here.